Featured Content

All Content

Substance Use and Addiction Stigma in Oncology Patients

Contemporary Clinic spoke with Gretchen McNally, nurse practitioner of hematology at Arthur G. James Cancer Hospital, about substance use disorder in oncology patients and addiction stigma.

NAPNAP to Host Town Hall on COVID-19 Vaccine

The National Association of Pediatric Nurse Practitioners (NAPNAP) is hosting a TeamPeds Town Hall event, titled “COVID-19 Update and Vaccine Development,” to discuss what health care professionals should expect related to vaccine development and distribution.

New Generic Methylphenidate Hydrochloride Tablets Available on the Market

Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of ADHD.

The Growth of Telehealth for Health Care Professionals

Contemporary Clinic spoke with Kelli Garber, lead nurse practitioner for school-based health and the center for telehealth at the Medical University of South Carolina and NAPNAP member, about the growth of telehealth and what health care professionals and nurse practitioners should consider when using telehealth.

Study: Rate of Flu Immunizations Could Parallel COVID-19 Vaccine Acceptance

Age, insurance status, and having a primary care provider are all important determinants, but short- and long-term interventions are necessary to increase vaccination rates.

Nurse Practitioners and National Immunization Awareness Month

Contemporary Clinic spoke with Lukia Beverly, pediatric nurse practitioner and co-chair of NAPNAP’s Immunization Special Interest Group, about National Immunization Awareness Month.

Study Shows Flu Vaccine May Reduce Risk of Alzheimer Disease

Flu vaccination may introduce proteins used by the body to learn how to fight Alzheimer disease later on.

FDA Approves Ophthalmic Solution for Treatment of Cystinosis

Drops of cysteamine ophthalmic solution are applied 4 times a day.

Study Finds Rates of E-Cigarettes, Marijuana Use Not Associated With Vaping-Related Lung Injuries

The results showed higher rates of vaping and marijuana use are associated with fewer EVALI cases per capita.

Department of Defense Awards Adaptive Phage Therapeutics $9.8 Million for Development of COVID-19 Vaccine

The Department of Defense awarded Adaptive Phage Therapeutics $9.8 million for the development of multiple high-priority, bacteriophage-based display vaccine candidates against COVID-19.